DRIVERS IN HTA DECISION-MAKING FOR CHOLESTEROL LOWERING PCSK9 INHIBITORS

被引：0
|
作者：
Kreeftmeijer, J. [1 ]
Dekkers, R. [1 ]
van Engen, A. [1 ]
机构：
[1] Quintiles Advisory Serv, Hoofddorp, Netherlands
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 07期
关键词：
D O I：
10.1016/j.jval.2016.09.1474
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSY157
引用
收藏
页码：A603 / A603
页数：1
相关论文
共 50 条
  • [1] Limitations of cholesterol lowering with PCSK9 inhibitors
    Thompson, Gilbert
    LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (04): : 241 - 243
  • [2] PCSK9 INHIBITORS PREFERENCES AND SHARED DECISION MAKING
    Mulder, J.
    Redekop, K.
    Galema-Boers, A.
    Kranenburg, L.
    Van Lennep, J. Roeters
    ATHEROSCLEROSIS, 2023, 379 : S168 - S169
  • [3] Lipid lowering with PCSK9 inhibitors
    Razvan T. Dadu
    Christie M. Ballantyne
    Nature Reviews Cardiology, 2014, 11 : 563 - 575
  • [4] Lipid lowering with PCSK9 inhibitors
    Dadu, Razvan T.
    Ballantyne, Christie M.
    NATURE REVIEWS CARDIOLOGY, 2014, 11 (10) : 563 - 575
  • [5] PCSK9 inhibitors for LDL lowering
    Walsh, Lames P.
    TRENDS IN CARDIOVASCULAR MEDICINE, 2015, 25 (07) : 575 - 577
  • [6] Cholesterol-Lowering Agents PCSK9 Inhibitors Today and Tomorrow
    Rosenson, Robert S.
    Hegele, Robert A.
    Koenig, Wolfgang
    CIRCULATION RESEARCH, 2019, 124 (03) : 364 - 385
  • [7] Cholesterol reduction with PCSK9 inhibitors
    Lambooij A.
    Huisarts en wetenschap, 2018, 61 (9) : 18 - 20
  • [8] PCSK9 Inhibitors: Novel Therapeutic Strategies for Lowering LDL-Cholesterol
    Wang, Yan
    Liu, Zhao-Peng
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2019, 19 (02) : 165 - 176
  • [9] PCSK9 Inhibition for Therapeutic Decision-Making Assessing the Value
    Weintraub, William S.
    Boden, William E.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (18) : 2309 - 2311
  • [10] Cholesterol Management in the Era of PCSK9 Inhibitors
    Svatikova, Anna
    Kopecky, Stephen L.
    CURRENT CARDIOLOGY REPORTS, 2017, 19 (09)
12345